BDX vs SHC
BDX: BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and researchers worldwide. SHC: A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma companies.
Side-by-side fundamentals
| Metric | BDX | SHC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $158.92 | $17.24 | |
| Market cap as of 2026-08-01 | $43.8B | $4.9B | |
| P/E as of 2026-08-01 | 39.78 | 43.24 | BDX lower |
| PEG as of 2026-08-01 | -24.04 | 4.31 | BDX lower |
| Net margin as of 2026-08-01 | +5.3% | +9.9% | SHC higher |
| Gross margin as of 2026-08-01 | +47.0% | +55.3% | SHC higher |
| Operating margin as of 2026-08-01 | +10.2% | +29.0% | SHC higher |
| ROE as of 2026-08-01 | +4.5% | +20.6% | SHC higher |
| ROA as of 2026-08-01 | +2.1% | +3.6% | SHC higher |
| Debt / equity as of 2026-08-01 | 0.72 | 3.59 | BDX lower |
| Revenue growth (YoY) as of 2026-08-01 | +2.4% | +7.4% | SHC higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | +5.1% | SHC higher |
| Dividend yield as of 2026-08-01 | +2.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-01 | 0.20 | 1.78 | |
| 1-year return as of 2026-07-27 close | +9.1% | +40.2% | SHC higher |
Fundamentals: market data, as of 2026-08-01. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.